Stephen Doster

Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known… Read More

Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops. Their tour de force raises the possibility that one day scientists will… Read More

Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops. Their tour de force raises the possibility that one day scientists… Read More

Chuck Sanders, vice dean of the Vanderbilt University School of Medicine Basic Sciences, Aileen M. Lange and Annie Mary Lyle Professor and professor of biochemistry, and Roy Zent, Thomas F. Frist Sr. Professor, professor of medicine and vice chair of research for… Read More

Vanderbilt University Medical Center and Vanderbilt University are launching a $17 million multiyear transformative program with support from the National Institutes of Health (NIH) to accelerate diversity, equity, inclusion and belonging in the biomedical research community. The institutions will build on prior successes in recruitment to strengthen hiring, promotion and… Read More

Chuck Sanders Thirty years into my faculty career, I now sometimes play the game of “professionally speaking, what would I have done differently over the course of the years if I had a chance to do it all over again?” I don’t indulge in this exercise to second-guess myself… Read More

Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known… Read More

By Kensey Bergdorf Ann Richmond In a continuation of previous work studying the role of chemokine receptor CXCR2 in immune cells published in Cancer Immunology Research, the lab of Ann Richmond, Ingram Professor of Cancer Biology and professor of pharmacology, has identified that same receptor as a regulator of melanoma… Read More

Atrial fibrillation (A-fib) — the most common cardiac arrhythmia (irregular heartbeat) — is associated with increased risk of stroke, heart failure, dementia and death. Antiarrhythmic drug therapy to prevent A-fib has remained elusive. The strongest genetic risk factors for A-fib in humans are variants in a chromosomal region including the gene… Read More

When Waddell Walker Hancock founded the A.B. Hancock Jr. Memorial Laboratory for Cancer Research 40 years ago at Vanderbilt, she was determined that the right combination of imagination, perseverance and scientific talent could win the fight against cancer. Hancock Lab researchers have earned many national honors and 13 patents for… Read More